Form 4 for PGNY Progyny, Inc.
Accepted 2024-03-27 00:00:00 ET · period of report 2024-03-25 · accession 0001551306-24-000049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-27 | 2024-03-25+ | PGNY | Schlanger David J | Executive COB, Dir | M - OptEx | $3.95 | +2,902 | 86.6K | +3% | +$11.5K |
| DM | 2024-03-27 | 2024-03-25+ | PGNY | Schlanger David J | Executive COB, Dir | S - Sale+OE | $37.63 | -2,902 | 86.3K | -3% | -$109.2K |
| DM | 2024-03-27 | 2024-03-25+ | PGNY | Schlanger David J | Executive COB, Dir | M - OptEx | $0.00 | -2,902 | 1.38M | -0.2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-25 | M | A | 2,597 | $3.95 | 88,909 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-26 | M | A | 305 | $3.95 | 86,617 | D | — | — | |
| 3 | Common | Common Stock | 2024-03-26 | S | D | 305 | $37.50 | 86,312 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $37.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2024-03-25 | S | D | 2,597 | $37.65 | 86,312 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.55 to $37.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-03-25 | M | D | 2,597 | $0.00 | 1,381,599 | D | $3.95 · — to 2029-05-23 | 2,597 Common Stock | (F4) These options are fully vested and exercisable. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-03-26 | M | D | 305 | $0.00 | 1,381,294 | D | $3.95 · — to 2029-05-23 | 305 Common Stock | (F4) These options are fully vested and exercisable. |